Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

H3K27Me3-nucleosome is a strong prognostic biomarker in Non-Small Cell Lung Cancer: interim results from the analysis of up to 832 patients at baseline

Friday, March 28, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses interim results from a study on H3K27Me3-nucleosome as a prognostic biomarker in Non-Small Cell Lung Cancer. The analysis involved up to 832 patients at baseline, indicating a strong correlation with patient outcomes. The findings were presented at the ELCC 2025 conference, highlighting their significance in cancer prognosis.
Price reaction · baseline $10.56 (2025-03-27 close) · hit pre-market · 5 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • H3K27Me3-nucleosome shows strong prognostic value.
  • Interim results based on a substantial patient cohort of 832.
  • Presented at a notable conference (ELCC 2025).

Full Press Release Details

Paper titled: H3K27Me3-nucleosome is a strong prognostic biomarker in Non-Small Cell Lung Cancer: interim results from the analysis of up to 832 patients at baseline
Marie Piecyk, Emmanuel Grolleau, Gaelle Lescuyer, Sébastien Couraud, Patrick Merle, Patrick Mas, Sébastien Larive, Michael Duruisseaux, Oriane Pelton, Gwenaelle Schnoering, Aristotelis Kotronoulas, Julie Candiracci, Marielle Herzog, Léa Payen1
Presented at ELCC 2025

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the significance of H3K27Me3-nucleosome?

H3K27Me3-nucleosome is identified as a strong prognostic biomarker in Non-Small Cell Lung Cancer.

How many patients were analyzed in the study?

The study analyzed interim results from up to 832 patients at baseline.

Where were the results presented?

The results were presented at the ELCC 2025 conference.

What type of cancer is the study focused on?

The study focuses on Non-Small Cell Lung Cancer.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Non-Small Cell Lung Cancer H3K27Me3 biomarker prognostic value
Last updated: Mar 28, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk